Estrogen Antagonists As Treatments for Sclerosing Disorders

The present invention relates to methods and compositions for treating a subject suffering from a sclerosing disorder, comprising administering, to the subject, an effective amount of an estrogen receptor antagonist ("ERANT"), wherein said ERANT has essentially no estrogen receptor agonist activity under physiologic conditions.

Attached files:


Patents:
WO 2,011,014,516

Inventor(s): FEGHALI-BOSTWICK CAROL A [US]; HERSHBERGER PAMELA ANNE [US]

Type of Offer: Licensing



« More Medical Patents

---